The Growth Strategy Series: Synthetic Biologist Striving for Sustainable Biotechnology
Cindy’s drive to apply her knowledge to real-world challenges and develop innovative enzyme-based solutions made HydRegen the perfect fit. With a background in synthetic biology, she was drawn to the company's mission to leverage enzymes to support a sustainable chemical industry. This alignment has allowed her to contribute significantly to HydRegen’s growth.
Introducing Tara: From Industrial Placement to Program Lead at HydRegen
I’m thrilled to be back at HydRegen in a role that merges my scientific background with business development. It's exciting to be at the forefront of bringing our innovative, sustainable technologies to market."
The Growth Strategy Series: A Chemist's Journey from Academia to a Startup
Becky’s decision to join HydRegen was motivated by her interest in being part of a startup’s dynamic and fast-paced environment. Attracted by the potential to take on diverse responsibilities to broaden her skill set and gain experience, she was also excited by the opportunity to witness and contribute to the company's growth. A decision that prompted her move from academia in the United States to the UK.
Our Summer 2024 process progress
We've spent the summer working on
commercially competitive Bio2Amine processes,
showcasing our tech running routinley in higher TRL reactors, and
demonstrating a 18-fold improvement in enzyme manufacturing increasing our cost-competitivity across the chemicals sector!
The Growth Strategy Series: A Closer Look at Yinqi’s Journey
At the core of HydRegen's mission to make chemical manufacturing safer and more sustainable lies a team of exceptional scientists dedicated to pushing the boundaries of biocatalysis. Among them is Yinqi, a biologist whose journey into the field has been driven by a passion for understanding and transforming the natural world.
HydRegen appoint Joe de Sousa as a Non-Executive Director
With HydRegen, I was immediately struck not only by the energy and ambition of the team, but also by the potential HydRegen technology has to make a real impact in the pharmaceutical sector and many others. Their innovative biocatalysis technology provides an efficient and sustainable alternative to traditional chemical manufacturing processes, and they have already started to demonstrate real world applications and impact.
HydRegen appoint John Boyle as a Scientist specialising in Organic Chemistry
HydRegen, the revolutionary bioscience company, is pleased to announce the appointment of John Boyle as a Scientist of Organic Chemistry. With more than 4 years’ experience in chemical biology and organic chemistry, John brings extensive knowledge of microbial biotransformation and recombinant enzymes.